Thermo Fisher Scientific (TMO) Enterprise Value (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Enterprise Value for 18 consecutive years, with $185.7 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Enterprise Value rose 25.58% year-over-year to $185.7 billion; the trailing twelve-month figure through Jun 2026 stood at $185.7 billion (up 25.58% YoY), and the FY2025 full-year result was $205.3 billion, up 7.58% from the prior year.
• Enterprise Value advanced to $185.7 billion in Q2 2026 per TMO's latest filing, from $172.8 billion in the prior quarter.
• Across five years, Enterprise Value topped out at $229.2 billion in Q2 2022 and bottomed at $147.9 billion in Q2 2025.
• Historically, Enterprise Value has averaged $197.0 billion across 5 years, with a median of $197.2 billion in 2022.
• The sharpest annual moves came in 2022 and 2025: Enterprise Value soared 31.93% in 2022, then slipped 26.97% in 2025.
• Over 5 years, Enterprise Value stood at $203.8 billion in 2022, then fell by 4.62% to $194.4 billion in 2023, then slipped by 1.86% to $190.8 billion in 2024, then rose by 7.58% to $205.3 billion in 2025, then fell by 9.51% to $185.7 billion in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered $185.7 billion, $172.8 billion, and $205.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.